Poly(ethylene oxide)-modified poly(ɛ-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer
- 11 April 2005
- journal article
- research article
- Published by Elsevier BV in International Journal of Pharmaceutics
- Vol. 293 (1-2), 261-270
- https://doi.org/10.1016/j.ijpharm.2004.12.010
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Nanoparticles of Biodegradable Polymers for Clinical Administration of PaclitaxelCurrent Medicinal Chemistry, 2004
- Cellular uptake and concentrations of tamoxifen upon administration in poly(ε-caprolactone) nanoparticlesAAPS PharmSci, 2003
- Colloidal drug carriers: achievements and perspectivesCellular and Molecular Life Sciences, 2003
- Biodegradable poly(ε-caprolactone) nanoparticles for tumor-targeted delivery of tamoxifenInternational Journal of Pharmaceutics, 2002
- Nanoparticles in cancer therapy and diagnosisAdvanced Drug Delivery Reviews, 2002
- Recent progress in drug delivery systems for anticancer agentsArchives of Pharmacal Research, 2002
- Preparation, characterization, and drug release behaviors of drug nimodipine‐loaded poly(ε‐caprolactone)‐poly(ethylene oxide)‐poly(ε‐caprolactone) amphiphilic triblock copolymer micellesJournal of Pharmaceutical Sciences, 2002
- Block copolymer micelles for drug delivery: design, characterization and biological significanceAdvanced Drug Delivery Reviews, 2001
- ‘Stealth’ corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorptionColloids and Surfaces B: Biointerfaces, 2000
- Drug targeting with nanoparticlesEuropean Journal of Drug Metabolism and Pharmacokinetics, 1994